Neuromod Successfully Closes €10.5 Million Series B Financing for Tinnitus Treatment Device Lenire®
Plans to recruit 40 employees over the next 12 months in Europe, starting in Ireland and Germany Proceeds to accelerate...
Staff
Implanet and SeaSpine Announce FDA Clearance of the Mariner Cap System
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical...
Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery
Medical Strategy Advisory Board (“MSAB”) to advise DRE on the convergence of expert AI-enabled technology in healthcare and the exponential...
PainReform Highlights Surgical Advantages of PRF-110
Studies demonstrate unique benefits of PRF-100 beyond analgesic activity PRF-110 addresses potential concerns in the local administration of anesthetic related...
DECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits
Donor Study Activities Began, Friday October 16th at FDA and CLIA Certified Testing Lab; Data to Also Be Used for...
StemoniX Announces Addition to Board of Directors
Company Announces Appointment of John Fletcher MAPLE GROVE, MN / ACCESSWIRE / October 19, 2020 / StemoniX, Inc. is pleased to...
Enzolytics, Inc. Shares BioClonetics Immunotherapeutics, Inc. Company Update
Enzolytics provides guidance on engagement of manufacturer and OTC Markets Membership PLANO, TX / ACCESSWIRE / October 19, 2020 /...
Skin Science Soul by Dr. Sholar Continues to Transform Austin Non-Invasive Aesthetics by Launching the EMSUITE
AUSTIN, TX / ACCESSWIRE / October 19, 2020 / Skin Science Soul by Dr. Alina Sholar, who launched the BTL...
Arizona State University/Halberd Initiate Patent Application for Unique New Engineered Class of Covid-19 Antibody
JACKSON CENTER, PA / ACCESSWIRE / October 19, 2020 / Halberd Corporation (OTC PINK:HALB) today announced the creation of a...
Sunshine Biopharma And University Of Georgia Team Up To Develop A New Anti-Coronavirus Drug
MONTREAL, QC / ACCESSWIRE / October 19, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
Havn Life Sciences Announces Appointment of Dennis Staudt to the Board of Directors & Senior Management Reorganization
VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"),...
IntraBio Reports Further Detail on Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C
IB1001 demonstrated statistically significant and clinically meaningful change in both the primary and secondary endpoints Significant improvement in gait, fine...
Avinger Announces First US Cases with TIGEREYE(TM) Image-Guided CTO Crossing Catheter
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first...
Planet 13 Expanding Las Vegas SuperStore
Planet 13 is expanding the largest dispensary in the world doubling the sales floor to service overwhelming customer demand and...
Nanosonics Announces trophon®2 Giveback Giveaway in Support of International Infection Prevention Week
Infection Prevention Solutions Company Joins APIC to Celebrate Healthcare Heroes INDIANAPOLIS--(BUSINESS WIRE)--#HLD--Nanosonics (ASX: NAN), a leader in infection prevention solutions,...
Dr. Augusto Sola, Masimo VP of Medical Affairs for Neonatology, Honored by the American Academy of Pediatrics with Pioneer Award
Dr. Sola Pioneered New Protocol Using Masimo SET® Pulse Oximetry That Dramatically Reduced Blindness and Eye Damage in Neonates IRVINE,...
Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer
Highly accomplished biotech executive with nearly two decades of industry leadership experience Topas is advancing its pipeline based on its...
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
Headline Results of MTX110 Phase I DIPG Study Phase II Dose Confirmed and Encouraging Survival Data ABINGDON, OXFORDSHIRE / ACCESSWIRE...
Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing
Co-led by new investors, Vesalius BioCapital III and BioMedPartners, with participation from all existing investors Funds to be used to...
Just – Evotec Biologics Receives Grant to Enable an Antibody Product for The Prevention of Covid-19
JUST - EVOTEC BIOLOGICS RECEIVES GRANT FOR COVID-19 MONOCLONAL ANTIBODY OPTIMISATION AND CELL LINE DEVELOPMENT FROM THE COVID-19 THERAPEUTICS ACCELERATOR...